Cardiomyocyte transplantation does not reverse cardiac remodeling in rats with chronic myocardial infarction Yutaka Sakakibara, MD, Keiichi Tambara,

Slides:

Advertisements

Similar presentations

Paracrine Action Enhances the Effects of Autologous Mesenchymal Stem Cell Transplantation on Vascular Regeneration in Rat Model of Myocardial Infarction

Advertisements

Therapeutic Effect of Midkine on Cardiac Remodeling in Infarcted Rat Hearts Shinya Fukui, MD, Satoru Kitagawa-Sakakida, MD, PhD, Sin Kawamata, MD, PhD,

Therapeutic angiogenesis with intramyocardial administration of basic fibroblast growth factor Michio Kawasuji, MD, Hiroshi Nagamine, MD, Masahiro Ikeda,

Direct epicardial shock wave therapy improves ventricular function and induces angiogenesis in ischemic heart failure Daniel Zimpfer, MD, Seyedhossein.

Successful Aortic Valve Replacement for Heyde Syndrome With Confirmed Hematologic Recovery Atsutomo Morishima, MD, Akira Marui, MD, PhD, Takeshi Shimamoto,

Repair of Myocardial Infarction by Epicardial Deposition of Bone Marrow Cell-Coated Muscle Patch in a Murine Model Laurent Barandon, MD, Thierry Couffinhal,

Cardiomyocyte Transplantation Improves Heart Function

Optimal time for cardiomyocyte transplantation to maximize myocardial function after left ventricular injury Ren-Ke Li, MD, PhD, Donald A.G. Mickle,

Comparative effects of mesenchymal progenitor cells, endothelial progenitor cells, or their combination on myocardial infarct regeneration and cardiac.

Hybrid Surgical Angiogenesis: Omentopexy Can Enhance Myocardial Angiogenesis Induced by Cell Therapy Taro Kanamori, MD, Go Watanabe, MD, Tamotsu Yasuda,

Paracrine Action Enhances the Effects of Autologous Mesenchymal Stem Cell Transplantation on Vascular Regeneration in Rat Model of Myocardial Infarction

Histone Modification Is Correlated With Reverse Left Ventricular Remodeling in Nonischemic Dilated Cardiomyopathy Emiko Ito, PhD, Shigeru Miyagawa, MD,

Repeated remote ischemic conditioning attenuates left ventricular remodeling via exosome-mediated intercellular communication on chronic heart failure.

Intraaortic balloon pumping for predominantly right ventricular failure after heart transplantation Osama E Arafa, MD, Odd R Geiran, MD, PhD, Kai Andersen,

Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects Jay G. Shake, MD, Peter J. Gruber, MD, PhD,

Ventricular Resynchronization by Multisite Pacing Improves Myocardial Performance in the Postoperative Single-Ventricle Patient Emile A. Bacha, MD, Frank.

Nitric oxide–generating β-adrenergic blocker nipradilol preserves postischemic cardiac function Hitoshi Horimoto, MD, Adam E Saltman, MD, PhD, Glenn.

Hartmuth B Bittner, MD The Annals of Thoracic Surgery

Combined transplantation of skeletal myoblasts and angiopoietic progenitor cells reduces infarct size and apoptosis and improves cardiac function in chronic.

Changfa Guo, MD, Husnain Kh

Ventricular septal rupture caused by myocardial bridging

Reversible Pulmonary Trunk Banding VIII: Intermittent Overload Causes Harmless Hypertrophy in Adult Goat Leonardo A. Miana, MD, PhD, Renato S. Assad,

Autologous smooth muscle cell transplantation improved heart function in dilated cardiomyopathy Kyung-Jong Yoo, MD, Ren-Ke Li, MD, PhD, Richard D. Weisel,

Myocardial tactile stiffness during acute reduction of coronary blood flow Kagami Miyaji, MD, Seiryo Sugiura, MD, Hirotaka Inaba, MD, Shinichi Takamoto,

Homing of intravenously infused embryonic stem cell-derived cells to injured hearts after myocardial infarction Jiang-Yong Min, MD, Xuling Huang, MD,

Randomized Study of Mononuclear Bone Marrow Cell Transplantation in Patients With Coronary Surgery Qiang Zhao, MD, Yongxin Sun, MD, Limin Xia, MD, Anqing.

Clifford H. Van Meter, MD (by invitation), William C

Marrow Stromal Cells as Universal Donor Cells for Myocardial Regenerative Therapy: Their Unique Immune Tolerance Rony Atoui, MD, MS, Juan-Francisco Asenjo,

Therapeutic angiogenesis induced by local autologous bone marrow cell implantation Kimikazu Hamano, MD, Tao-Sheng Li, MD, Toshiro Kobayashi, MD, Ken Hirata,

Autosynchronized systolic unloading during left ventricular assist with a centrifugal pump Satoshi Kono, MDa, Kazunobu Nishimura, MD, PhDa, Takeshi Nishina,

Therapeutic Potential of Human Umbilical Cord Derived Stem Cells in a Rat Myocardial Infarction Model Kai Hong Wu, MD, PhD, Bin Zhou, PhD, Cun Tao Yu,

Proteasome Inhibition Attenuates Infarct Size and Preserves Cardiac Function in a Murine Model of Myocardial Ischemia-Reperfusion Injury William E. Stansfield,

Intramyocardial injection of tannic acid attenuates postinfarction remodeling: A novel approach to stabilize the breaking extracellular matrix Hao Zhang,

Hemodynamic Effects of Human Atrial Natriuretic Peptide After Modified Fontan Procedure Takeshi Hiramatsu, Yasuharu Imai, Yoshinori Takanashi, Kazuhiro.

Cardiac dysfunction induced by experimental myocardial infarction impairs the host defense response to bacterial infection in mice because of reduced.

Ventricular assist device programs: design and function

Basic fibroblast growth factor may improve devascularized sternal healing Atsushi Iwakura, MD, Yasuhiko Tabata, PhD, Kazunobu Nishimura, MD, Tatsuo Nakamura,

Echocardiographic evidence of right ventricular remodeling after transplantation Holger K Eltzschig, MD, Tomislav Mihaljevic, MD, John G Byrne, MD, Raila.

Injectable Microsphere Gel Progressively Improves Global Ventricular Function, Regional Contractile Strain, and Mitral Regurgitation After Myocardial.

Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation Shinji Tomita, MD, PhD, Donald.

Modification of Infarct Material Properties Limits Adverse Ventricular Remodeling Masato Morita, MD, Chad E. Eckert, PhD, Kanji Matsuzaki, MD, PhD, Mio.

Anish Krishnan, BSc, Douglas Drak, BSc, Shisan Bao, PhD, David S

Transplantation of cryopreserved cardiomyocytes

Cellular therapy reverses myocardial dysfunction

Significant improvement of heart function by cotransplantation of human mesenchymal stem cells and fetal cardiomyocytes in postinfarcted pigs Jiang-Yong.

A novel atrial volume reduction technique to enhance the Cox maze procedure: Initial results Akira Marui, MD, PhD, Takeshi Nishina, MD, PhD, Keiichi.

Organ perfusion with hemopump device assistance with and without intraaortic balloon pumping Bart Meyns, MD, Yousuke Nishimura, MD, Rozalia Racz, MD,

Mechanisms of Cardiomyoplasty: Comparative Effects of Adynamic Versus Dynamic Cardiomyoplasty Brian D. Mott, Joong Hwan Oh, Yoshio Misawa, Joe Helou,

Layered implantation of myoblast sheets attenuates adverse cardiac remodeling of the infarcted heart Naosumi Sekiya, MD, Goro Matsumiya, MD, PhD, Shigeru.

Association of electrostimulation with cell transplantation in ischemic heart disease Abdel Shafy, MD, Thomas Lavergne, MD, Christian Latremouille, MD,

Elimination of Ischemic Mitral Regurgitation Does Not Alter Long-Term Left Ventricular Remodeling in the Ovine Model Kanji Matsuzaki, MD, PhD, Masato.

Prevascularization with gelatin microspheres containing basic fibroblast growth factor enhances the benefits of cardiomyocyte transplantation Yutaka.

Ventriculocoronary artery bypass results using a mesh-tipped device in a porcine model Robert W Emery, MD, Frazier Eales, MD, Clifford H Van Meter, MD,

Xenotransplant cardiac chimera: immune tolerance of adult stem cells

Optimal dose and mode of delivery of Na+/H+ exchange-1 inhibitor are critical for reducing postsurgical ischemia-reperfusion injury Joel S Corvera, MD,

Intermittent Antegrade Tepid Versus Cold Blood Cardioplegia in Elective Myocardial Revascularization Andrew C Fiore, MD, Marc T Swartz, BA, Robert Nevett,

Spironolactone alleviates late cardiac remodeling after left ventricular restoration surgery Masaki Tsukashita, MD, Akira Marui, MD, PhD, Takeshi Nishina,

Adenosine-enhanced ischemic preconditioning provides myocardial protection equal to that of cold blood cardioplegia James D McCully, PhD, Masahisa Uematsu,

Charles R. Bridges, MD, James M

Peter Pecher, MD, Bernd A Schumacher, MD

Richard Lee, Takashi Nitta, Ralph A. Schmid, Richard B

Edward P Chen, Hartmuth B Bittner, Damian M Craig, R

Minimally invasive direct coronary artery bypass in a cardiac transplant recipient with allograft vasculopathy Ivan Aleksic, MD, PhD, Jarowit A Piotrowski,

Ascending versus descending aortic balloon

Coronary bypass flow during use of intraaortic balloon pumping and left ventricular assist device Takeo Tedoriya, MD, Michio Kawasuji, MD, Naoki Sakakibara,

Reduced inotropic support after aprotinin therapy during pediatric cardiac operations Carl F Wippermann, MD, Franz X Schmid, MD, Balthasar Eberle, MD,

Skeletal muscle ventricle aortic counterpulsation: function during chronic heart failure Bhavik G Patel, MD, Sachin H Shah, MD, Lou I Astra, MD, Robert.

Andrew D Cochrane, Shobhna Pathik, Joseph J Smolich, Robert A

Transmural Differences in Myocardial Function and Metabolism During Direct Left Ventricular to Coronary Artery Sourcing Sandra de Zeeuw, PhD, Cornelius.

Beneficial effect of autologous cell transplantation on infarcted heart function: comparison between bone marrow stromal cells and heart cells Terrence.

Presentation transcript:

Cardiomyocyte transplantation does not reverse cardiac remodeling in rats with chronic myocardial infarction Yutaka Sakakibara, MD, Keiichi Tambara, MD, Fanglin Lu, MD, Takeshi Nishina, MD, Noritoshi Nagaya, MD, Kazunobu Nishimura, MD, PhD, Masashi Komeda, MD, PhD The Annals of Thoracic Surgery Volume 74, Issue 1, Pages 25-30 (July 2002) DOI: 10.1016/S0003-4975(02)03601-9

Fig 1 Experimental protocol. (Blood sample = measurement of atrial natriuretic peptide in plasma;Cath. = measurement of left ventricular pressure and volume using a micromanometer-tipped catheter; Echo = echocardiography; LAD = left anterior descending artery;Treatment = culture medium injection or fetal cardiomyocyte transplantation.) The Annals of Thoracic Surgery 2002 74, 25-30DOI: (10.1016/S0003-4975(02)03601-9)

Fig 2 (A through D) Results of cardiac function by echocardiography between fetal cardiomyocyte transplantation (TX) and control groups before and after treatment. There were no significant differences in each group before versus after treatment. The TX group had smaller left ventricular (LV) end-systolic dimension and higher fractional shortening and fractional area change. (E) Scar thickness. The ventricular wall in infarct area was thicker in the TX group. (F) Plasma levels of atrial natriuretic peptide (ANP; pg/mL) between the two groups before and after treatment. No significant differences were shown before versus after treatment in each group, or between the groups in each time point. (NS = not significant.) The Annals of Thoracic Surgery 2002 74, 25-30DOI: (10.1016/S0003-4975(02)03601-9)

Fig 3 Photomicrographs of transplanted fetal cardiomyocytes in the periinfarct area of the left venticular free wall in the transplantation group 4 weeks after the second operation (magnification: A, ×40; B, ×200), and transplanted cardiomyocytes labeled by PKH26 red fluorescent dye (magnification: C, ×40; D, ×100). Panel B is enlargement of inset in A; panel D is enlargement of inset in C. The Annals of Thoracic Surgery 2002 74, 25-30DOI: (10.1016/S0003-4975(02)03601-9)